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Abstract
The aim of the present study is to examine all cases of intraosseous benign ameloblastomas treated between 1970 
and 2010 in a single institution and to look for a possible correlation between the histopathological aspects and 
the demographical and clinical parameters, as well as the treatment outcome. The data of a total number of 44 
patients were retrieved from the records. Nine patients were excluded because of doubt about the correct diagnosis 
(8 patients) or because of an extra-osseous presentation (1 patient). 
No statistically significant differences were found between the histopathological (sub)types of ameloblastomas 
and the demographical and clinical parameters, nor between the histopathological (sub)types and treatment outco-
me. Of the 28 patients treated by enucleation, in 17 patients one or more recurrences occurred, with no significant 
predilection for any histopathological (sub)type, including the unicystic type. There were no significant differen-
ces in the recurrence rate after enucleation in patients below and above the age of 20 years either. In six out of 17 
patients with a recurrence, the recurrent lesion showed a different histopathological subtype than was encountered 
in the primary. In two cases a change from solid/multicystic to desmoplastic ameloblastomas was noticed. 
In conclusion, the current histopathological classification of benign intraosseous ameloblastoma does not seem to 
have clinical relevance with the possible exception of the luminal unicystic ameloblastoma that has been removed 
in toto, unfragmented. Since no primary desmoplastic ameloblastomas were encountered in the present study no 
further comments can be made on this apparently rare entity.
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Introduction
The ameloblastoma is a histologically almost always 
benign odontogenic tumour of the jaw bones. Howe-
ver, it has a strong tendency to recur after conservative 
surgical removal. Extra-osseous occurrence is rather 
exceptional. Malignant ameloblastomas are extremely 
rare. The aetiology is unknown. The incidence of ame-
loblastomas is estimated at 0,5 per million population 
per year, although in some parts in the world, e.g. South 
Africa, a higher incidence has been reported (1,2).
Clinically, the tumour often presents as an otherwise 
asymptomatic swelling of the posterior mandible, fre-
quently being associated with an unerupted tooth. Most 
patients are aged between 30 and 60 years at the time 
of diagnosis. There is no gender predilection. Multiple 
presentation is exceedingly rare. On conventional radio-
graphs the ameloblastoma may present as a unilobular or 
multilobular corticated radiolucency. Bony septae may 
result in a honeycomb appearance. Resorption of roots 
may or may not be present. The radiographic differen-
tial diagnosis includes a variety of odontogenic cysts 
and tumours, particularly the keratocystic odontogenic 
tumour, as well as non-odontogenic cysts and tumours, 
such as a central giant cell lesion, fibro-osseous lesions 
and simple bone cyst. It has been mentioned that the 
desmoplastic ameloblastoma is often characterized ra-
diographically by a mottled, mixed radiolucency/radio-
pacity with diffuse margins, suggestin a fibro-osseous 
lesion (3).
In the 2005 World Health Organization classification 
the benign ameloblastoma is divided into 1) solid/multi-
cystic, 2) extra-osseous/peripheral, 3) desmoplastic, and 
4) unicystic (3). The solid/multicystic ameloblastoma 
can histopathologically be divided into a follicular and 
a plexiform type (Figs. 1 and 2); the follicular type can 
be further subdivided into a spindle cell type, an acan-
thomatous type, a granular type and a basal cell type 
(3). The plexiform type contains basal cells arranged 
in anastomosing strands with an inconspicuous stella-
te reticulum. The stroma is usually delicate, often with 
cystlike degeneration (3). The unicystic ameloblastoma 
represents an ameloblastoma variant that on gross exa-
mination, and not based on the appearance on the ra-
diograph, presents as a cyst. Two histopathological va-
riants are recognized, being the luminal variant and the 
mural variant (3) (Fig. 3). The extraosseous type shows 
the histopathogical cell types and patterns as seen in 
the solid/multicystic type. In the desmoplastic type the 
stromal component dominates, compressing the odon-
togenic epithelial components (3) (Fig. 4). 
The preferred treatment of the ameloblastoma is wide 
surgical removal, with the possible exception of the 
luminal variant of unicystic ameloblastoma for which 
enucleation may be justified (4). 
The aim of the present study is to examine all cases of 
intraosseous benign ameloblastoma registered as such 
in the period between 1970 and 2010 and to look for a 
possible correlation between the histopathological as-
pects and the demographical and clinical parameters as 
well as the treatment outcome, particularly in patients 
who initially have been treated by enucleation. Further-
more, the aim is to examine whether histopathological 
subtypes differ between primary ameloblastomas and 
one or more of their recurrences. 
Fig. 1. Follicular ameloblastoma showing peripheral palisading and 
central reticulum stellate pattern (H.E.; orig.magn. x 200).
Fig. 2. Plexiform ameloblastoma with anastomosing strands and 
cords of tumour cells (H.E.; orig.magn. x 200).
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Material and Methods
In the period between September 1970 and September 
2010, 44 cases of a benign ameloblastoma and one case 
of a malignant ameloblastoma were encountered in the 
files of the Department of Oral and Maxillofacial Sur-
gery/Oral Pathology at the VUmc/ACTA, Amsterdam, 
The Netherlands. The single case of a primary malig-
nant ameloblastoma has been excluded from the present 
study. 
Nine of the 44 patients were excluded because of do-
ubt about the correct diagnosis of ameloblastomas (8 
patients) or because of an extraosseous presentation 
(1 patient). Of the remaining 35 patients data on age, 
gender, localization, radiographs, type of treatment and 
recurrences were retrieved from the files (Table 1). Of 
the 28 patients initially treated by enucleation, 17 pa-
tients experienced one or more recurrences, including 
11 patients treated previously elsewhere. In one patient 
a single cervical lymph node metastasis was found in 
a recurrent, otherwise benign ameloblastoma (“metas-
tatic ameloblastoma”); this patient has been described 
in more detail elsewhere (5). The mean follow-up of the 
patients amounted 8.3 years.
The histopathological typing of the biopsies and surgi-
cal specimens has been performed by one experienced 
oral pathologist. The intraobserver variation with re-
gard to the histopathogical subtyping at an interval of 
six months has been assessed as well. Since it was not 
possible to characterize all solid/multicystic types in ei-
ther a follicular or a plexiform type, a category of mixed 
follicular/plexiform type has been introduced. 
The results were statistically analysed using the Kappa, 
Student T-test, Chi square test and the Anova test. 
Results
The results are shown in (Tables 2 and 3). No statistica-
lly significant differences were found between unicys-
tic and solid/multicystic ameloblastomas with regard 
to age and gender (p=0.926 and p=0.735, respectively). 
Unicystic ameloblastomas only occurred in the mandi-
ble (p=0.016) and the solid/multicystic ameloblastomas 
mainly occurred in the mandible (p=0.004). There was 
no significant difference in the recurrence rate after 
enucleation of a unicystic or a solid/mulitcystic amelo-
blastoma (p=0.544). There were no significant differen-
ces in the recurrence rate after enucleation in patients 
below and above the age of 20 years either.
No significant differences were found between the sub-
types of solid/multicystic ameloblastoma with regard to 
age, gender, localization and treatment outcome (Table 
3).
In 17 of the 28 patients treated with enucleation, one 
or more recurrences were observed. In six of these 
patients, the histopathological type of the recurrence 
differed from the primary tumor. For example, in two 
patients with an initial plexiform and mixed type ame-
loblastoma, the recurrence showed a desmoplastic va-
riant. The unicystic ameloblastomas did not recur as a 
unicystic lesion.
In (Table 4) the intraobserver variation is shown, the 
kappa being 0.766. The variation was mainly found in 
typing follicular and plexiform type, versus mixed type 
ameloblastoma.
Fig. 3. Unicystic ameloblastoma (luminal type), showing ameloblas-
tomatous epithelial lining the "cyst" wall (H.E.; orig. magn. x 200).
Fig. 4. Desmoplastic ameloblastoma. Epithelial tumour islands sur-
rounded by a zone of loose-structured connective tissue (H.E.; orig.
magn. x 100).
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1
Mean age (in years, at time of the primary diagnosis) 31.6 (10-70) 
 Patients below the age of 20 years 11
 Patients above the age of 20 years 24
Gender  
 Male 17
 Female 18
Localization 
 Mandible 29
 Maxilla 6
 Ratio (maxilla : mandible) 1 : 4.8 
Treatment of the initial ameloblastoma 
 Enucleation 28
  One or more recurrences 17
 Radical surgery 7
  One or more recurrences 0
Histopathological typing of the primary ameloblastoma 
 Unicystic ameloblastoma 7
 Solid/multicystic ameloblastoma 28
            Follicular type 10
            Plexiform type 11
           Mixed  follicular/plexiform 7
Desmoplastic ameloblastoma 0
Follow-up (in years) 8.3 
(± S.D. 7.13) 
Table 1. Demographical and clinical data, and histopathological typing of patients with a 
benign intraosseous ameloblastoma (n=35).
 1 
   
      Unicystic (n=7)                    Solid/Multicystic (n=28)                P value 
Mean age (years) 31.1 (±SD 10.9) 31.7 (±SD 15.2) *P = 0.926 
Gender   ĹP = 0.735 
 Male 3 14 
 Female 4 14 
Localization   ĹP = 0.864 
 Mandible 7 22 
 Maxilla 0 6 
Mandible : Maxilla 7 : 0 22 : 6  
Treatment outcome   ĹP = 0.544 
 Enucleation 6 22 
  Recurrence 3 14  
 
Table 2. Relation between unicystic versus multicystic types on demographic and clinical 
parameters (n=35).
* Student T-test
↑ Chi square test
↕ Anova test
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Discussion
The excluded patients. Nine patients were initially 
diagnosed with a benign ameloblastoma but have been 
excluded because of extra-osseous localization (1 pa-
tient) or because of doubt about the correct diagnosis of 
ameloblastoma in the initial lesion (8 patients). In four 
of these eight patients some nests of ameloblastomalike 
cells were found in the follicle of a surgically removed 
wisdom tooth during routine microscopic examination. 
In such event the question arises how many ameloblas-
tomalike cells are required to justify the diagnosis of 
ameloblastoma (6). In several studies the presence of 
ameloblastomalike cells in follicles of asymptomatic 
third molars has been reported , the percentages varying 
from 1.5% up to 11% (7-9). In such instances, it seems 
justified to follow-up such patients for a somewhat arbi-
trarily chosen period of ten years. 
Another excluded patient was diagnosed with a metas-
tasis of a previously treated cutaneous basal cell carci-
noma, extending into the cortical bone of the mandible 
and mimicking an ameloblastoma. Yet another patient 
was previously diagnosed with a diagnosis of squamous 
odontogenic tumour (SOT) (10); the recurrent lesion 
clearly showed the histological features of an ameloblas-
toma. One patient with a recurrent ameloblastoma was 
initially diagnosed as a keratocystic odontogenic tumor 
(KCOT). The immunohistochemical marker calretinin, 
which is supposed to discriminate between KCOT and 
ameloblastoma (11,12), was not helpful in this case One 
patient was excluded because of a possible diagnosis of 
odontoameloblastoma. 
Demographical data. In our series the demographical 
data were in accordance with the results of other stu-
dies. No relation was found with the histopathological 
subtypes (13,14). Patients from some of the developing 
countries and dark-skinned patients are younger and 
 1 
   
Solid/Multicystic 
Total Follicular Plexiform Mixed P value 
Number of patients 28 10 11 7  
Mean age (years) 31.7 29 32.6 34.1 ĽP = 0.778 
 (±SD 15.2) (±SD 7.3) (±SD 17.3) (±SD 20.9)  
Gender     ĹP = 0.134 
Male 14 3 8 3  
Female 14 7 3 4  
Localization     ĹP = 0.864 
Mandible 22 8 9 5  
Maxilla 6 2 2 2  
Mandible : Maxilla 22 : 6 (P<0.05)     
Treatment outcome     ĹP = 0.213 
Enucleation 22 8 8 6  
Recurrence 14 7 4 3  
 
1
 Unicystic Follicular Plexiform Mixed  
December 2010    Total 
Unicystic 6 0 0 0 6 
Follicular 1 8 0 0 9 
Plexiform 0 0 11 3 14 
Mixed 0 2 0 4 6 
Total 7 10 11 7 35 
Table 3. Relation between the three subtypes of solid/multicystic ameloblastomas and demographic and clinical data 
(n=28).
Table 4. Intraobserver variation in the histopathological subtyping of ameloblastomas (n=35). 
↑ Chi square test
↕ Anova test
Kappa = 0.766
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Asian patients with an ameloblastoma seem slightly ol-
der than Caucasian patients (15). In the present series 11 
patients were below the age of 20 years. The age limit 
of 20 years has been used in the study by Ord et al. (16). 
There were no significant differences in the recurrence 
rate after enucleation in patients below and above the 
age of 20 years. This result does not give support to the 
belief that ameloblastomas in children behave in a less 
aggressive way than in adults (16).
It is known that socioeconomic conditions have a ma-
jor impact on demographic as well as on clinical outco-
me (17). In the Netherlands most ameloblastomas are 
found during routine radiographic examination by the 
dentist. Therefore, one would expect a younger age than 
in patients diagnosed with an ameloblastoma in some 
of the developing countries. Apparently, this is not the 
case (18). There may be genetic and/or external factors 
influencing the pathogenesis of ameloblastomas that 
might explain this age discrepancy.
Clinical data. There were no significant differences 
between the clinical parameters of the different types 
of ameloblastoma in comparison with the data from the 
literature (19). In our series only mandibular unicystic 
ameloblastomas were observed. The reported prevalen-
ce for maxillary localization varies between 8 to 33% 
in all unicystic cases (18). The prevalence of unicystic 
ameloblastomas in the present series (7 out of 35 cases, 
being 20%) is rather high compared to the prevalence 
figure of 5% of all ameloblastoma cases reported by 
Darshani Gunawardhana et al. (19). 
Treatment outcome. The treatment outcome, i.e. recu-
rrence rate after enucleation, was similar for all histo-
pathological (sub)types, including the unicystic types. 
This is in contrast to the general belief that unicystic 
ameloblastomas have a lower recurrence rate and, the-
refore, might be treated less aggressively (18). The recu-
rrence of unicystic ameloblastomas may be explained 
by fragmental removal with possible tumor spill.
All patients in whom a preoperative diagnosis of ame-
loblastoma was available were advised to have radical 
surgery. In the 28 patients who have been treated by enu-
cleation, the recurrence rate in these patients amounted 
approximately 60 percent (17 out of 28 patients) during 
a mean follow-up of 8.3 years.
In eight of the 11 patients below the age of 20 years 
(73%), a recurrence was observed. A lower recurrence 
rate in children as being reported in other studies might 
be explained by a higher percentage of unicystic amelo-
blastomas in those studies (16). 
Histopathogical aspects. In nine cases of solid/multi-
cystic ameloblastoma an equal distribution of a follicu-
lar and a plexiform pattern was noticed within one sam-
ple. For these cases a category of mixed type follicular 
and plexiform was added. In five of these nine cases 
there was a rather high intra-observer variability, the 
overall intra-observer kappa being 0.766. The variation 
was mainly found in typing follicular and plexiform 
type, versus mixed type ameloblastoma.
In six of 17 patients with a recurrence, the primary le-
sion was typed different. In two cases a change from 
solid/multicystic ameloblastoma to desmoplastic ame-
loblastomas was noticed. It is tempting to speculate that 
the desmoplastic type mainly or perhaps even exclusi-
vely occurs in cases of recurrence. However, by exami-
ning the stromal reaction for collagen type VI in desmo-
plastic and solid/multicystic stroma, it was concluded 
that the desmoplastic stroma was not to be interpreted 
as simple scar tissue but as newly produced connective 
tissue; it has been suggested that TGF-beta produced by 
epithelial tumour cells of desmoplastic ameloblastoma 
play a part in the prominent desmoplastic matrix forma-
tion (20,21). Also in view of the clinicoradiographic fea-
tures of desmoplastic ameloblastomas, its recognition 
as a separate entity seems fully justified (3,22).
The recurrence of three unicystic ameloblastomas can 
probably be explained by fragmentation during remo-
val of the primary tumor. It is, indeed, often difficult 
to remove a cystic lesion in tot without fragmentation. 
It should be realised that a diagnosis of unicystic amo-
loblastoma may not always be easy to establish with 
certainty (23,24). Parts of the epithelial lining of a (uni)
cystic ameloblastoma may lack the pathognomonic 
features an ameloblastoma. A biopsy of a primary uni-
cystic ameloblastoma or a biopsy of a recurrent, solid/
multicystic ameloblastoma, may not always show the 
typical features of ameloblastoma, which may result in 
an underdiagnosis and, as a result, possibly in incorrect 
management.
In the 11 patients below the age of 20 years, nine solid/
multicystic and two unicystic ameloblastomas were no-
ticed. This is in contrast to the suggestion that unicystic 
ameloblastomas are more common among children than 
among adults (16). 
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